Stock VVEO3 CM HOSPITALAR S/A
Add to a list
To use this feature you must be a member
Log inSign up

All News CM Hospitalar S/A

Equities

VVEO3

BRVVEOACNOR0

Market Closed - Sao Paulo
Other stock markets
 21:07:00 17/07/2024 BST 		5-day change 1st Jan Change
2.4 BRL -2.83% Intraday chart for CM Hospitalar S/A -8.75% -82.80%
05-10 CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-26 CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2023
CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
CM Hospitalar S/A(BOVESPA:VVEO3) added to Brazil Small Cap Index
CI
CM Hospitalar S/A Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
CM Hospitalar S/A Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2022
CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2022
CI
CM Hospitalar S/A acquired remaining stake in Far.me.
CI
CM Hospitalar S/A Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
CM Hospitalar S/A agreed to acquire Neve Industria e Comercio de Produtos Cirurgicos and Nutrifica Comercio de Nutricao Enteral e Parenteral for BRL 110 million.
CI
CM Hospitalar S/A Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Brazil's Viveo sees $23 mln EBITDA growth after multiple acquisitions
RE
CM Hospitalar S/A entered into a definite agreement to acquire Pro-Formula Quimioterapica Ltda from Vinci Impacto e Retorno IV, managed by Vinci Capital Gestora de Recursos Ltda. and others.
CI
CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
CM Hospitalar S/A acquired Boxifarma.
CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VVEO3 Stock
  4. News CM Hospitalar S/A